Home/Filings/4/0001654954-17-005032
4//SEC Filing

NAVIDEA BIOPHARMACEUTICALS, INC. 4

Accession 0001654954-17-005032

CIK 0000810509operating

Filed

May 22, 8:00 PM ET

Accepted

May 23, 5:40 PM ET

Size

5.7 KB

Accession

0001654954-17-005032

Insider Transaction Report

Form 4
Period: 2017-05-19
Latkin Jed
Interim COO
Transactions
  • Purchase

    Common Stock, $.001 par value

    2017-05-19$0.45/sh+14,159$6,38731,359 total
  • Purchase

    Common Stock, $.001 par value

    2017-05-22$0.45/sh+11,200$5,03942,559 total

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000810509

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 5:40 PM ET
Size
5.7 KB